Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease

Abstract Background Alterations in levels of circulating micro-RNAs might reflect within organ signaling or subclinical tissue injury that is linked to risk of diabetes and cardiovascular risk. We previously found that serum levels of miR-483-5p is correlated with cardiometabolic risk factors and in...

Full description

Bibliographic Details
Main Authors: Widet Gallo, Filip Ottosson, Cecilia Kennbäck, Amra Jujic, Jonathan Lou S. Esguerra, Lena Eliasson, Olle Melander
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-021-01964-0
_version_ 1818623906191245312
author Widet Gallo
Filip Ottosson
Cecilia Kennbäck
Amra Jujic
Jonathan Lou S. Esguerra
Lena Eliasson
Olle Melander
author_facet Widet Gallo
Filip Ottosson
Cecilia Kennbäck
Amra Jujic
Jonathan Lou S. Esguerra
Lena Eliasson
Olle Melander
author_sort Widet Gallo
collection DOAJ
description Abstract Background Alterations in levels of circulating micro-RNAs might reflect within organ signaling or subclinical tissue injury that is linked to risk of diabetes and cardiovascular risk. We previously found that serum levels of miR-483-5p is correlated with cardiometabolic risk factors and incidence of cardiometabolic disease in a case–control sample from the populations-based Malmö Diet and Cancer Study Cardiovascular Cohort (MDC-CC). We here aimed at replicating these findings and to test for association with carotid atherosclerosis. Methods We measured miR-483-5p in fasting serum of 1223 healthy subjects from the baseline examination of the population-based, prospective cohort study Malmö Offspring Study (MOS) and correlated miR-483-5p to cardiometabolic risk factors and to incidence of diabetes mellitus and coronary artery disease (CAD) during 3.7 (± 1.3) years of follow-up using logistic regression. In both MOS and MDC-CC we related mir-483-5p to carotid atherosclerosis measured with ultrasound. Results In cross-sectional analysis miR-483-5p was correlated with BMI, waist circumference, HDL, and sex. After adjustment for age and sex, the association remained significant for all risk factors except for HDL. Logistic regression analysis showed significant associations between miR-483-5p and new-onset diabetes (OR = 1.94, 95% CI 1.06–3.56, p = 0.032) and cardiovascular disease (OR = 1.99, 95% CI 1.06–3.75, p = 0.033) during 3.7 (± 1.3) years of follow-up. Furthermore, miR-483-5p was significantly related with maximum intima-media thickness of the carotid bulb in MDC-CC (p = 0.001), but not in MOS, whereas it was associated with increasing number of plaques in MOS (p = 0.007). Conclusion miR-483-5p is related to an unfavorable cardiometabolic risk factor profile and predicts diabetes and CAD, possibly through an effect on atherosclerosis. Our results encourage further studies of possible underlying mechanisms and means of modifying miR-483-5p as a possible interventional target in prevention of cardiometabolic disease.
first_indexed 2024-12-16T18:48:30Z
format Article
id doaj.art-f915fbe55a294f0dbbfd7d6d77ca52c0
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-16T18:48:30Z
publishDate 2021-04-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-f915fbe55a294f0dbbfd7d6d77ca52c02022-12-21T22:20:45ZengBMCBMC Cardiovascular Disorders1471-22612021-04-012111710.1186/s12872-021-01964-0Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic diseaseWidet Gallo0Filip Ottosson1Cecilia Kennbäck2Amra Jujic3Jonathan Lou S. Esguerra4Lena Eliasson5Olle Melander6Department of Clinical Sciences-Malmö, Hypertension and Cardiovascular Disease, Lund UniversityDepartment of Clinical Sciences-Malmö, Hypertension and Cardiovascular Disease, Lund UniversityDepartment of Emergency and Internal Medicine, Skane University HospitalDepartment of Clinical Sciences-Malmö, Hypertension and Cardiovascular Disease, Lund UniversityDepartment of Clinical Sciences Malmö, Lund University Diabetes Centre, Lund University MalmöDepartment of Clinical Sciences Malmö, Lund University Diabetes Centre, Lund University MalmöDepartment of Clinical Sciences-Malmö, Hypertension and Cardiovascular Disease, Lund UniversityAbstract Background Alterations in levels of circulating micro-RNAs might reflect within organ signaling or subclinical tissue injury that is linked to risk of diabetes and cardiovascular risk. We previously found that serum levels of miR-483-5p is correlated with cardiometabolic risk factors and incidence of cardiometabolic disease in a case–control sample from the populations-based Malmö Diet and Cancer Study Cardiovascular Cohort (MDC-CC). We here aimed at replicating these findings and to test for association with carotid atherosclerosis. Methods We measured miR-483-5p in fasting serum of 1223 healthy subjects from the baseline examination of the population-based, prospective cohort study Malmö Offspring Study (MOS) and correlated miR-483-5p to cardiometabolic risk factors and to incidence of diabetes mellitus and coronary artery disease (CAD) during 3.7 (± 1.3) years of follow-up using logistic regression. In both MOS and MDC-CC we related mir-483-5p to carotid atherosclerosis measured with ultrasound. Results In cross-sectional analysis miR-483-5p was correlated with BMI, waist circumference, HDL, and sex. After adjustment for age and sex, the association remained significant for all risk factors except for HDL. Logistic regression analysis showed significant associations between miR-483-5p and new-onset diabetes (OR = 1.94, 95% CI 1.06–3.56, p = 0.032) and cardiovascular disease (OR = 1.99, 95% CI 1.06–3.75, p = 0.033) during 3.7 (± 1.3) years of follow-up. Furthermore, miR-483-5p was significantly related with maximum intima-media thickness of the carotid bulb in MDC-CC (p = 0.001), but not in MOS, whereas it was associated with increasing number of plaques in MOS (p = 0.007). Conclusion miR-483-5p is related to an unfavorable cardiometabolic risk factor profile and predicts diabetes and CAD, possibly through an effect on atherosclerosis. Our results encourage further studies of possible underlying mechanisms and means of modifying miR-483-5p as a possible interventional target in prevention of cardiometabolic disease.https://doi.org/10.1186/s12872-021-01964-0MiR-483-5pCardiometabolic diseaseAtherosclerosisDiabetes mellitus
spellingShingle Widet Gallo
Filip Ottosson
Cecilia Kennbäck
Amra Jujic
Jonathan Lou S. Esguerra
Lena Eliasson
Olle Melander
Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
BMC Cardiovascular Disorders
MiR-483-5p
Cardiometabolic disease
Atherosclerosis
Diabetes mellitus
title Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
title_full Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
title_fullStr Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
title_full_unstemmed Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
title_short Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
title_sort replication study reveals mir 483 5p as an important target in prevention of cardiometabolic disease
topic MiR-483-5p
Cardiometabolic disease
Atherosclerosis
Diabetes mellitus
url https://doi.org/10.1186/s12872-021-01964-0
work_keys_str_mv AT widetgallo replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease
AT filipottosson replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease
AT ceciliakennback replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease
AT amrajujic replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease
AT jonathanlousesguerra replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease
AT lenaeliasson replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease
AT ollemelander replicationstudyrevealsmir4835pasanimportanttargetinpreventionofcardiometabolicdisease